OM Stock Performance, Insider Transaction and News

OM - Outset Medical, Inc.

Market Cap	0.95B	P/E	-	EPS this Y	23.30%	Ern Qtrly Grth	-
Income	-172.8M	Forward P/E	-6.56	EPS next Y	13.00%	50D Avg Chg	-7.00%
Sales	130.38M	PEG	-0.08	EPS past 5Y	-	200D Avg Chg	-9.00%
Dividend	N/A	Price/Book	4.41	EPS next 5Y	23.80%	52W High Chg	-37.00%
Recommedations	2.40	Quick Ratio	4.27	Shares Outstanding	51.70M	52W Low Chg	70.00%
Insider Own	1.82%	ROA	-29.73%	Shares Float	49.64M	Beta	1.98
Inst Own	102.54%	ROE	-93.69%	Shares Shorted/Prior	8.58M/8.52M	Price	19.36
Gross Margin	22.24%	Profit Margin	-132.54%	Avg. Volume	450,914	Target Price	5.79
Oper. Margin	-122.44%	Earnings Date	May 8	Volume	715,740	Change	-4.91%

Healthcare | Medical Devices | United States

About Outset Medical, Inc.

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Outset Medical, Inc. News

05/06/24	Outset Medical's TabloCart with Prefiltration Receives FDA 510(k) Clearance
05/01/24	Outset Medical to Present at Upcoming Investor Conferences
04/19/24	Outset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
04/18/24	Outset Medical (OM) Inks Multi-Year Deal to Boost Home Dialysis
04/17/24	Outset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S.
04/15/24	Outset Medical Partners with American Nephrology Nurses Association to Support Nephrology Nursing and Patient Care
03/13/24	Outset Medical Announces Appointment of Medical Technology Veteran Brent D. Lang to its Board of Directors
03/05/24	Why Dialysis Stocks Are up Today
02/26/24	Outset Medical to Present at the 44th Annual TD Cowen Health Care Conference
02/23/24	Outset Medical Full Year 2023 Earnings: EPS Misses Expectations
02/22/24	Outset Medical, Inc. (NASDAQ:OM) Q4 2023 Earnings Call Transcript
02/22/24	Q4 2023 Outset Medical Inc Earnings Call
02/21/24	Outset Medical Inc (OM) Reports Mixed Q4 and Full Year 2023 Results
02/21/24	Outset Medical Reports Fourth Quarter and Full Year 2023 Financial Results
02/05/24	Outset Medical, Inc. (OM) Expected to Beat Earnings Estimates: Should You Buy?
02/05/24	Outset Medical to Report Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, February 21, 2024
08:30 AM	Outset Medical Reports Unaudited Fourth Quarter and 2023 Revenue, Provides 2024 Revenue and Non-GAAP Gross Margin Guidance
01/03/24	Outset Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
11/29/23	Outset Medical to Present at BofA Home Care Conference
11/25/23	5 Struggling Stocks to Buy at a Discount

OM Chatroom

BoBiden Posted - 15 hours ago

$OM

Alejos11 Posted - 16 hours ago

$OM

Hsons Posted - 21 hours ago

$OM People buy at the top and complaint why it dropped when early investors are taking profits and they blame shorts and mm all the time. Buy now thank me later bought 6100 this is a easy 40-50%

Alejos11 Posted - 21 hours ago

$OM

WorkHardNow_EnjoyLater Posted - 1 day ago

$OM

DavidScott Posted - 1 day ago

On watch tomorrow (momentum) // Part 1 🔥📈📚 $SGE $XBP $NUVO $MULN $OM

Alejos11 Posted - 1 day ago

$OM

Alejos11 Posted - 1 day ago

$OM

SadyK189 Posted - 1 day ago

Top Stocks to watch tomorrow 2 / 3: $OM $UPLD $RYDE $MI $NRXP

vpalani Posted - 1 day ago

$OM this is solid company will continue my DD and I am going to hold it till past $10 this has all potential 🍀📈🎯

Alejos11 Posted - 1 day ago

$OM

Alejos11 Posted - 1 day ago

$OM

Stocksrunner Posted - 1 day ago

🚀📈 Top Gainers Alert: $PRFT EQT to buy United States Digital Consultancy Perficient for $3 Billion! $OM Outset Medical stock rallies on FDA clearance of dialysis device! $PSTV Plus Therapeutics announces private placement financing of up to $18 million! $FRPT Freshpet shares soar on impressive Q1 earnings and revenue beats! 🐾 Stay tuned for more market updates and exciting opportunities! 📊

Hockeyguy419 Posted - 1 day ago

$OM This should be an interesting few days. With earnings on Wednesday, I am interested to see what their guidance will be with this news today.

FINTECFA Posted - 1 day ago

$OM power hour….

FINTECFA Posted - 1 day ago

$OM volume dried up… but it should go up the rest of the week 100% imho…

Jamesiam Posted - 1 day ago

$OM easy short

Jamesiam Posted - 1 day ago

$OM who the hell paid more than $5 a share for this company. How was it ever $20? $40? Crazy

Hockeyguy419 Posted - 1 day ago

$OM this company will be sucessful. As someone who works in dialysis, I can tell you my company lost numerous acute contracts to tablo Now, with the 510k clearance and the deal with us renal, their home program will explode. The federal govt wants like 60% of dialysis patients at home by the end of this year or 2025, so there is consoderable pressure on dialysis providers to comply

hi_tech_low_life Posted - 1 day ago

Why Outset Medical Shares Are Up Today $OM https://www.benzinga.com/news/24/05/38651160/why-outset-medical-shares-are-up-today

Jamesiam Posted - 1 day ago

$OM how many reverse splits have they done?

Zaje Posted - 1 day ago

$OM even with a good news this market is gone to hell they control everything

FINTECFA Posted - 1 day ago

$OM $10 by weekend..

LoveRetailFroth Posted - 1 day ago

$OM Back in

LoveRetailFroth Posted - 1 day ago

$OM Will get back in

gerbey Posted - 1 day ago

$OM on watch at this level

Zaje Posted - 1 day ago

$OM bull trap or bear trap let see

PitSniper Posted - 1 day ago

$OM AGBA IS THE PLAY

Hsons Posted - 1 day ago

$OM Bought and will hold til 6+ in this week i would be worried if stock goes down with vol but this drop is normal

WorkHardNow_EnjoyLater Posted - 1 day ago

$OM so literally the thing that tanked this thing last summer from 40$ to here ... FDA had written a warning for the company to take off its website that the pre filtration was not FDA approved. Outset worked with FDA and submitted the right stuff to get it approved and now it's approved. This stock is significantly undervalued here. It should continue to steadily climb. I found $TNDM back in 2018 at 2$ a share and it skyrocketed. This has way more potential being in a lucrative dialysis industry with a leading partner. Don't be afraid to add here IMO

Analyst Ratings

BTIG	Buy	Apr 8, 24
RBC Capital	Sector Perform	Jan 12, 24
Morgan Stanley	Equal-Weight	Dec 4, 23
Morgan Stanley	Equal-Weight	Nov 14, 23
RBC Capital	Outperform	Oct 13, 23
Stifel	Buy	Oct 13, 23
B of A Securities	Underperform	Oct 13, 23
Morgan Stanley	Equal-Weight	Aug 24, 23
RBC Capital	Outperform	Aug 17, 23

Insider Trades	Relationship	Date	Transactions	Cost($)	#Shares	Value($)	#Share Own	SEC Form 4
Williamson Steven S.	Chief Commercial Off.. Chief Commercial Officer	Jan 12	Sell	4.29	996	4,273	322,847	01/17/24
Trigg Leslie	Chair and CEO Chair and CEO	Jan 12	Sell	4.29	8,126	34,861	838,411	01/17/24
Racine Jean-Olivier	Chief Technology Off.. Chief Technology Officer	Jan 12	Sell	4.29	723	3,102	273,696	01/17/24
Porter Stacey L.	Chief People Officer Chief People Officer	Jan 12	Sell	4.29	768	3,295	61,448	01/17/24
Nash Marc	SVP Operations and R.. SVP Operations and R&D	Jan 12	Sell	429	678	290,862	243,717	01/17/24
Brottem John L.	General Counsel General Counsel	Jan 12	Sell	4.29	1,480	6,349	248,387	01/17/24
Ahmed Nabeel	Chief Financial Offi.. Chief Financial Officer	Jan 12	Sell	4.29	1,726	7,405	316,997	01/17/24
Williamson Steven S.	Chief Commercial Off.. Chief Commercial Officer	Jan 08	Sell	5.49	7,055	38,732	105,939	01/08/24
Trigg Leslie	Chair and CEO Chair and CEO	Jan 08	Sell	5.49	14,188	77,892	389,099	01/08/24
Racine Jean-Olivier	Chief Technology Off.. Chief Technology Officer	Jan 08	Sell	5.49	3,905	21,438	73,781	01/08/24
Porter Stacey L.	Chief People Officer Chief People Officer	Jan 08	Sell	5.49	4,766	26,165	58,630	01/08/24
Brottem John L.	General Counsel General Counsel	Jan 08	Sell	5.49	7,344	40,319	48,807	01/08/24
Ahmed Nabeel	Chief Financial Offi.. Chief Financial Officer	Jan 08	Sell	5.49	10,709	58,792	76,819	01/08/24
Ahmed Nabeel	Chief Financial Offi.. Chief Financial Officer	Jun 01	Sell	20.83	990	20,622	92,716	06/01/23
Brottem John L.	General Counsel General Counsel	May 16	Sell	20.02	4,067	81,421	58,945	05/17/23
Brottem John L.	General Counsel General Counsel	May 16	Option	9.48	1,415	13,414	61,677	05/17/23
Racine Jean-Olivier	Chief Technology Off.. Chief Technology Officer	May 16	Sell	19.91	735	14,634	79,227	05/16/23
Porter Stacey L.	Chief People Officer Chief People Officer	May 16	Sell	19.91	626	12,464	64,704	05/16/23
Ahmed Nabeel	Chief Financial Offi.. Chief Financial Officer	May 16	Sell	19.91	1,532	30,502	93,706	05/16/23
Trigg Leslie	Chair and CEO Chair and CEO	May 16	Sell	19.91	2,962	58,973	409,489	05/16/23
Williamson Steven S.	Chief Commercial Off.. Chief Commercial Officer	May 16	Sell	19.91	681	13,559	117,212	05/16/23
Williamson Steven S.	Chief Commercial Off.. Chief Commercial Officer	May 08	Sell	19.83	10,000	198,300	117,893	05/08/23
Ahmed Nabeel	Chief Financial Offi.. Chief Financial Officer	May 03	Sell	20.0	990	19,800	95,238	05/05/23
Brottem John L.	General Counsel General Counsel	May 03	Sell	20	1,414	28,280	61,597	05/05/23
Brottem John L.	General Counsel General Counsel	May 03	Option	9.48	1,414	13,405	63,011	05/05/23
Trigg Leslie	Chair and CEO Chair and CEO	May 03	Sell	20	40,000	800,000	412,451	05/05/23
Trigg Leslie	Chair and CEO Chair and CEO	May 03	Option	4.03	40,000	161,200	422,959	05/05/23
Trigg Leslie	Chair and CEO Chair and CEO	Mar 01	Sell	22.48	30,000	674,400	412,451	03/02/23
Trigg Leslie	Chair and CEO Chair and CEO	Mar 01	Option	3.88	30,000	116,400	442,451	03/02/23
Vazquez Martin	Chief Operating Offi.. Chief Operating Officer	Mar 01	Sell	22.33	5,000	111,650	103,112	03/02/23
Vazquez Martin	Chief Operating Offi.. Chief Operating Officer	Mar 01	Option	3.88	5,000	19,400	108,112	03/02/23
Vazquez Martin	Chief Operating Offi.. Chief Operating Officer	Feb 01	Sell	29.48	24,500	722,260	104,435	03/02/23
Vazquez Martin	Chief Operating Offi.. Chief Operating Officer	Feb 01	Option	3.88	24,500	95,060	110,935	03/02/23
Ahmed Nabeel	Chief Financial Offi.. Chief Financial Officer	Feb 16	Sell	24.36	1,559	37,977	95,350	02/16/23
Porter Stacey L.	Chief People Officer Chief People Officer	Feb 16	Sell	24.36	627	15,274	63,908	02/16/23
Racine Jean-Olivier	Chief Technology Off.. Chief Technology Officer	Feb 16	Sell	24.36	748	18,221	78,540	02/16/23
Trigg Leslie	Chair and CEO Chair and CEO	Feb 16	Sell	24.36	3,015	73,445	411,029	02/16/23
Vazquez Martin	Chief Operating Offi.. Chief Operating Officer	Feb 16	Sell	24.37	1,931	47,058	102,504	02/16/23
Williamson Steven S.	Chief Commercial Off.. Chief Commercial Officer	Feb 16	Sell	24.36	694	16,906	126,471	02/16/23
Brottem John L.	General Counsel General Counsel	Feb 16	Sell	24.36	1,358	33,081	66,422	02/16/23
Trigg Leslie	Chair and CEO Chair and CEO	Feb 01	Sell	28.06	30,000	841,800	414,044	02/02/23
Trigg Leslie	Chair and CEO Chair and CEO	Feb 01	Option	3.88	30,000	116,400	444,044	02/02/23
Williamson Steven S.	Chief Commercial Off.. Chief Commercial Officer	Jan 27	Sell	27.92	3,023	84,402	127,165	01/30/23
Vazquez Martin	Chief Operating Offi.. Chief Operating Officer	Dec 01	Option	3.88	5,000	19,400	54,290	12/02/22
Vazquez Martin	Chief Operating Offi.. Chief Operating Officer	Dec 01	Sell	20.85	5,000	104,250	49,290	12/02/22
Trigg Leslie	Chair and CEO Chair and CEO	Dec 01	Option	3.88	30,000	116,400	311,526	12/02/22
Trigg Leslie	Chair and CEO Chair and CEO	Dec 01	Sell	20.85	30,000	625,500	290,243	12/02/22
Brottem John L.	General Counsel General Counsel	Nov 30	Option	9.48	12,761	120,974	43,805	12/01/22
Brottem John L.	General Counsel General Counsel	Nov 30	Sell	20.34	12,761	259,559	31,044	12/01/22
Hinrichs James F.	Director Director	Nov 22	Buy	17.84	7,500	133,800	47,668	11/22/22